Virginia L. Wyss

Safety, Pharmacokinetics, and Pharmacodynamics of Drotrecogin Alfa (Activated) in Children With Severe Sepsis

Phil Barton, André C. Kalil, Simon Nadel et al. · PEDIATRICS · 2004 · 125 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Minimal sequence requirement of thrombin receptor agonist peptide

Kwan Y. Hui, Joseph A. Jakubowski, Virginia L. Wyss et al. · Biochemical and Biophysical Research Communications · 1992 · 89 citations

Life Sciences, Biochemistry, Molecular Biology +14

Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies

Jean‐Louis Vincent, Simon Nadel, Demetrios J. Kutsogiannis et al. · Critical Care · 2005 · 77 citations · Full text

Veterinary Medicine, Pharmacology, Pharmacotherapy +13

Structure-activity relationships of arylimidazopyridine cardiotonics: discovery and inotropic activity of 2-[2-methoxy-4-(methylsulfinyl)phenyl]-1H-imidazo[4,5-c]pyridine

David W. Robertson, E. E. Beedle, Joseph H. Krushinski et al. · Journal of Medicinal Chemistry · 1985 · 73 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

Effects of L-carnitine administration on $$\dot V_{o_{2{\text{ }}max} } $$ and the aerobic-anaerobic threshold in normoxia and acute hypoxia

Virginia L. Wyss, Gian Pasquale Ganzit, A. Rienzi · European Journal of Applied Physiology · 1990 · 58 citations

Life Sciences, Pharmacology, Physiology +14